XTX Topco Ltd Buys New Position in Teladoc Health, Inc. (NYSE:TDOC)

XTX Topco Ltd bought a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) during the 1st quarter, according to its most recent filing with the SEC. The firm bought 69,988 shares of the health services provider's stock, valued at approximately $557,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. American Century Companies Inc. lifted its stake in shares of Teladoc Health by 18.1% in the fourth quarter. American Century Companies Inc. now owns 209,718 shares of the health services provider's stock worth $1,906,000 after acquiring an additional 32,213 shares in the last quarter. Norges Bank acquired a new stake in Teladoc Health during the 4th quarter valued at approximately $1,618,000. Geode Capital Management LLC increased its holdings in Teladoc Health by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock worth $35,894,000 after purchasing an additional 22,664 shares during the last quarter. Federated Hermes Inc. raised its position in shares of Teladoc Health by 232.6% in the 4th quarter. Federated Hermes Inc. now owns 337,597 shares of the health services provider's stock valued at $3,069,000 after purchasing an additional 236,102 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its stake in shares of Teladoc Health by 15.5% during the 4th quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider's stock valued at $51,582,000 after buying an additional 763,265 shares during the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Fernando M. Rodrigues sold 4,174 shares of the business's stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $6.91, for a total transaction of $28,842.34. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Carlos Nueno sold 3,958 shares of the firm's stock in a transaction on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total value of $27,151.88. Following the transaction, the insider directly owned 17,645 shares in the company, valued at $121,044.70. This trade represents a 18.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 18,656 shares of company stock worth $128,189 in the last three months. 0.58% of the stock is owned by company insiders.

Teladoc Health Stock Performance

Shares of TDOC traded up $0.02 during midday trading on Friday, hitting $6.97. 6,007,119 shares of the stock traded hands, compared to its average volume of 7,044,817. The business's 50 day moving average price is $7.71 and its two-hundred day moving average price is $8.44. The firm has a market capitalization of $1.23 billion, a PE ratio of -5.86 and a beta of 1.76. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67. Teladoc Health, Inc. has a 1-year low of $6.35 and a 1-year high of $15.21.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.27) by $0.08. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The firm had revenue of $631.90 million during the quarter, compared to analyst estimates of $621.91 million. During the same period in the previous year, the business posted ($0.38) EPS. Teladoc Health's revenue was down 1.6% on a year-over-year basis. Equities research analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on TDOC. Evercore ISI raised their price target on shares of Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a research report on Wednesday, July 9th. Stifel Nicolaus reduced their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a research note on Thursday, May 1st. Citigroup dropped their target price on shares of Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a research report on Friday, April 25th. Canaccord Genuity Group cut their target price on shares of Teladoc Health from $14.00 to $12.00 and set a "buy" rating on the stock in a research note on Thursday, May 1st. Finally, Mizuho began coverage on Teladoc Health in a research note on Friday, July 25th. They issued a "neutral" rating and a $10.00 price target for the company. Twelve investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat, Teladoc Health presently has an average rating of "Hold" and a consensus price target of $9.76.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.